Pfizer says COVID-19 vaccine more than 90% effective in kids
The shots could begin in early November, with the first children in line fully protected by Christmas, if regulators give the go-ahead Kid-size doses of Pfizer’s COVID-19 vaccine appear safe and nearly 91% effective at preventing symptomatic infections in 5- to 11-year-olds, according to study details released Friday as the U.S. considers opening vaccinations to…